Home
ADAPT Pharma, Inc.

ADAPT Pharma, Inc. Market Share Analysis for May 2026

Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats.

Health > Biotechnology and Pharmaceuticals

Domainadaptpharma.com

Year Founded2013

Employees51 - 200

Annual Revenue$5M - $10M

ADAPT Pharma, Inc.

ADAPT Pharma, Inc. (including company regionals)

adaptpharma.com

See more website traffic and engagement information

ADAPT Pharma, Inc. Revenue up to May 2026 is 5M - 10M

revenue generated by ADAPT Pharma, Inc. top domains

ADAPT Pharma, Inc. top domains revenue over 3 years

Revenue for ADAPT Pharma, Inc. top domains

adaptpharma.com5M - 10M

See more with Sales Intelligence

Total visits to ADAPT Pharma, Inc.'s top domains

Understand ADAPT Pharma, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in ADAPT Pharma, Inc.'s top domains

Analyze ADAPT Pharma, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on ADAPT Pharma, Inc.'s top domains

See how ADAPT Pharma, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

ADAPT Pharma, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by ADAPT Pharma, Inc.

These are the website technologies, by industry, used by ADAPT Pharma, Inc. top domains

Advertising (3)

DoubleClick

Content Management System (3)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from ADAPT Pharma, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdaptpharma launched NARCANDirect.com on May 1st '18.For instance, in May 2018, ADAPT Pharma, Inc., a subsidiary of Emergent Biosolutions Inc., launched NARCANDirect.com, an online platform for purchasers of NARCAN Nasal Spray (NARCAN).

NewsEmergent Testing, LLC acquired Adaptpharma on Jan 1st '18.Since acquiring Adapt Pharma in 2018, Gaithersburg-based Emergent BioSolutions has produced the nasal spray version of naloxone, a medication designed to reverse an opioid overdose.

NewsAdaptpharma launched Narcan nasal spray 4 on Feb 1st '21.For instance, Adapt Pharma Inc., in February, commercially introduced the Narcan nasal spray 4mg within the U.S. market.